EP3094336A4 - Method for inducing angiogenesis - Google Patents

Method for inducing angiogenesis Download PDF

Info

Publication number
EP3094336A4
EP3094336A4 EP15737660.9A EP15737660A EP3094336A4 EP 3094336 A4 EP3094336 A4 EP 3094336A4 EP 15737660 A EP15737660 A EP 15737660A EP 3094336 A4 EP3094336 A4 EP 3094336A4
Authority
EP
European Patent Office
Prior art keywords
inducing angiogenesis
angiogenesis
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP15737660.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3094336A1 (en
Inventor
Thomas J. Koob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mimedx Group Inc
Original Assignee
Mimedx Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mimedx Group Inc filed Critical Mimedx Group Inc
Publication of EP3094336A1 publication Critical patent/EP3094336A1/en
Publication of EP3094336A4 publication Critical patent/EP3094336A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
EP15737660.9A 2014-01-17 2015-01-20 Method for inducing angiogenesis Ceased EP3094336A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461928986P 2014-01-17 2014-01-17
PCT/US2015/012087 WO2015109329A1 (en) 2014-01-17 2015-01-20 Method for inducing angiogenesis

Publications (2)

Publication Number Publication Date
EP3094336A1 EP3094336A1 (en) 2016-11-23
EP3094336A4 true EP3094336A4 (en) 2018-02-14

Family

ID=53543554

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15737660.9A Ceased EP3094336A4 (en) 2014-01-17 2015-01-20 Method for inducing angiogenesis

Country Status (5)

Country Link
US (3) US10052351B2 (https=)
EP (1) EP3094336A4 (https=)
JP (1) JP7464348B2 (https=)
AU (1) AU2015206236B2 (https=)
WO (1) WO2015109329A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
US10517931B2 (en) 2013-01-17 2019-12-31 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9827293B2 (en) 2013-01-17 2017-11-28 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9655948B1 (en) 2013-01-17 2017-05-23 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9662355B2 (en) 2013-01-18 2017-05-30 Mimedx Group, Inc. Methods for treating cardiac conditions
WO2015109329A1 (en) * 2014-01-17 2015-07-23 Mimedx Group, Inc. Method for inducing angiogenesis
US10894066B2 (en) * 2014-03-06 2021-01-19 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9814746B2 (en) * 2014-06-15 2017-11-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US10363278B2 (en) 2014-06-15 2019-07-30 Amnio Technology Llc Frozen therapeutic dose and package
WO2016111899A1 (en) 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
JP7391508B2 (ja) * 2015-09-03 2023-12-05 ミメディクス グループ インコーポレイテッド 胎盤増殖因子組成物の非外科的かつ限局的な送達
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
JP7011135B2 (ja) * 2016-02-19 2022-02-10 佳秀工業株式会社 血管内皮増殖因子産生促進剤の製造方法及び発毛剤の製造方法、並びに血管内皮増殖因子産生促進剤及び発毛剤
EP3471701A4 (en) * 2016-06-21 2020-02-19 The Regents of the University of California WOUND HEALING WITH BRAF INHIBITORS
WO2018140363A1 (en) * 2017-01-27 2018-08-02 Aziyo Biologics, Inc. Lyophilized placental composite sheet and uses thereof
US10743996B2 (en) * 2017-03-24 2020-08-18 Robert L. Bundy Amnion putty for cartilage repair
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
CA3135546A1 (en) * 2019-04-04 2020-10-08 THT Biomaterials GmbH A novel human-material-based platform technology for tissue engineering
JP7684908B2 (ja) * 2019-04-16 2025-05-28 ライフネット ヘルス 出産組織由来の生成物並びにその調製及び使用
AU2021225836A1 (en) 2020-02-28 2022-09-15 Elutia Inc. Placental tissue compositions and methods
WO2024196980A1 (en) * 2023-03-22 2024-09-26 Wake Forest University Health Sciences Recombinant protein compositions useful for wound healing

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013171752A1 (en) * 2012-05-16 2013-11-21 Minovia Therapeutics Ltd. Compositions and methods for inducing angiogenesis
US20150010609A1 (en) * 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products

Family Cites Families (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272204A (en) 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
GB1427143A (en) 1972-06-01 1976-03-10 Hodson S A Transfer of freeze-dried specimens
US4865871A (en) 1983-08-23 1989-09-12 Board Of Regents The University Of Texas System Method for cryopreparing biological tissue
US4745771A (en) 1983-08-23 1988-05-24 Board Of Regents, The University Of Texas System Apparatus and method for cryopreparing biological tissue for ultrastructural analysis
MX163953B (es) 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
AU6129486A (en) 1985-07-02 1987-01-30 Target Therapeutics, Inc. Vaso-occlusive collagen composition and method
US4847049A (en) 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
EP0290442A4 (en) 1986-11-19 1990-07-03 Chemex Pharmaceuticals Inc MEDICINAL PREPARATIONS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS.
US4807442A (en) 1986-12-03 1989-02-28 Board Of Regents The University Of Texas System Cryo-slamming apparatus and method for ultrarapid cooling of biological samples
US4968325A (en) 1987-08-24 1990-11-06 Centre Quebecois De Valorisation De La Biomasse Fluidized bed gasifier
US4964280A (en) 1989-08-17 1990-10-23 Board Of Regents Method and apparatus for cryopreparing biological tissue
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
JPH03176064A (ja) 1989-12-05 1991-07-31 Hoechst Japan Ltd 創面被覆材
DE3942954A1 (de) 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur herstellung von aldehyden
CA2051092C (en) 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
KR100195325B1 (ko) 1991-07-10 1999-06-15 구본준 폴리머 제거방법
US5409690A (en) 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
CA2140053C (en) 1994-02-09 2000-04-04 Joel S. Rosenblatt Collagen-based injectable drug delivery system and its use
US7101857B2 (en) 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
DE19719398A1 (de) 1997-05-07 1998-11-12 Amsco Finn Aqua Gmbh Verfahren zur Steuerung eines Gefriertrocknungsprozesses
GB2345638A (en) 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
ATE424181T1 (de) 1999-06-25 2009-03-15 Procter & Gamble Topische antimikrobielle zusammensetzungen
AUPQ196799A0 (en) 1999-08-02 1999-08-26 Pinfold, Ann Method of preservation of amnion and uses thereof
JP4397082B2 (ja) 1999-12-09 2010-01-13 有限会社ジャパン・オフサルミック・コンサルタンツ 移植用細胞片及びその作成方法
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US6893462B2 (en) 2000-01-11 2005-05-17 Regeneration Technologies, Inc. Soft and calcified tissue implants
US6652583B2 (en) 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
KR100377921B1 (ko) 2000-05-04 2003-03-29 정원태 엑시머레이저 각막절제술에서의 안연고 제조방법
US6565960B2 (en) 2000-06-01 2003-05-20 Shriners Hospital Of Children Polymer composite compositions
KR20010000588A (ko) 2000-10-07 2001-01-05 이종훈 통신시스템을 이용한 클립아트 및 고화질 포토이미지다운로드 방법
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
WO2003032735A1 (en) 2001-10-18 2003-04-24 Lifecell Corporation Remodeling of tissues and organs
ITRM20020119A1 (it) 2002-03-05 2003-09-05 Geymonat Spa Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
AU2003250666A1 (en) 2002-07-29 2004-02-16 Asahi Kasei Kabushiki Kaisha Stem cells for treating pancreatic damage
WO2004026244A2 (en) 2002-09-18 2004-04-01 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
WO2004055156A2 (en) 2002-12-17 2004-07-01 Technion Research And Development Foundation Ltd. A vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
WO2005072790A1 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Device for directional cooling of biological matter
JP2005218585A (ja) 2004-02-04 2005-08-18 National Institute For Materials Science 医療用材料及びその製造方法
US7794490B2 (en) 2004-06-22 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices with antimicrobial and biodegradable matrices
EP1796693A2 (en) 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Implantable tissue compositions and method
JPWO2006025395A1 (ja) * 2004-08-31 2008-05-08 慶彦 清水 キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
KR100622676B1 (ko) 2004-11-24 2006-09-19 합명회사 신흥기업사 풍량제어 하향 송풍식 열풍순환 벌크 건조기
US20060166361A1 (en) 2004-12-21 2006-07-27 Agnieszka Seyda Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
CN103356706B (zh) 2005-03-31 2016-01-20 斯丹姆涅恩有限公司 促进无疤愈合或改善皮肤外观的美容制剂
BRPI0611739A2 (pt) 2005-06-10 2011-12-20 Celgene Corp colágeno de atelopeptìdeo, composição, método e kit para aumentar, avolumar ou substituir tecido de um mamìfero, e, processos para preparar e para reticular colágeno de atelopeptìdeo, e para reduzir a quantidade de partìculas virais em uma composição de colágeno
US20070021762A1 (en) 2005-07-13 2007-01-25 Qing Liu Ocular plug formed from placenta derived collagen biofabric
GB0514567D0 (en) 2005-07-15 2005-08-24 Univ Nottingham Surgical membrane
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US20070299043A1 (en) 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
CA2626460A1 (en) 2005-10-18 2007-04-26 Organogenesis, Inc. Antimicrobial collagenous constructs
CN101534865A (zh) 2005-10-19 2009-09-16 Ibc药品公司 生物活性装配体的制备方法及其用途
EP1948259B1 (en) 2005-10-26 2017-03-22 Genesis Technologies Limited Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products
US7960165B2 (en) 2005-12-01 2011-06-14 James Wright Method and apparatus for drying organic material
WO2007076522A2 (en) * 2005-12-28 2007-07-05 Ethicon, Incorporated Treatment of peripheral vascular disease using postpartum-derived cells
WO2007083984A1 (en) 2006-01-23 2007-07-26 Gwangju Institute Of Science And Technology Conjugate comprising pharmaceutical active compound covalently bound to mucoadhesive polymer and transmucosal delivery method of pharmaceutical active compound using the same
EP1998742A2 (en) 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
TW200817019A (en) 2006-07-10 2008-04-16 Univ Columbia De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
WO2008048663A2 (en) 2006-10-18 2008-04-24 Bacterin International, Inc. Novel process for devitalized/acellular tissue for transplantation
AU2007339257B2 (en) 2006-12-27 2013-01-10 Shriners Hospitals For Children Woven and/or braided fiber implants and methods of making same
US20080233552A1 (en) 2007-03-22 2008-09-25 David Hui-Kang Ma Method of cross-linking amnion to be an improved biomedical material
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
ES2840251T3 (es) 2007-07-10 2021-07-06 Lifecell Corp Composiciones acelulares de matriz tisular para reparación de tejidos
US7856737B2 (en) 2007-08-28 2010-12-28 Mathews Company Apparatus and method for reducing a moisture content of an agricultural product
EP4559488A3 (en) 2007-09-07 2025-08-13 MiMedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
US20100317677A1 (en) 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
MX2010003019A (es) 2007-09-19 2010-04-30 Pluristem Ltd Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
WO2009048780A1 (en) 2007-10-08 2009-04-16 The University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
US20090090022A1 (en) 2007-10-09 2009-04-09 Hememics Biotechnologies, Inc. Desiccation Chamber and Methods for Drying Biological Materials
US20110129520A1 (en) 2008-04-25 2011-06-02 Simon Bogdansky Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use
US9216077B2 (en) 2008-05-16 2015-12-22 Mimedx Group, Inc. Medical constructs of twisted lengths of collagen fibers and methods of making same
GB0816496D0 (en) 2008-09-10 2008-10-15 Zhao Xiaobin Hyaluronic acid cryogel
WO2010042205A2 (en) 2008-10-09 2010-04-15 Mimedx, Inc. Methods of making biocomposite medical constructs and related constructs including artificial tissues, vessels and patches
CN101433556A (zh) 2008-12-05 2009-05-20 成都青山利康药业有限公司 含胎盘成分的保健品组合物及制备方法
WO2010083466A1 (en) 2009-01-16 2010-07-22 Cedars-Sinai Medical Center Methods and compositions for cardiac tissue regeneration
US9393227B2 (en) 2009-02-04 2016-07-19 The Brigham And Women's Hospital, Inc. Nanoscale platinum compounds and methods of use thereof
US20100199514A1 (en) 2009-02-10 2010-08-12 Vermont Organics Reclamation Inc. Optimized apparatus and method for manure management
US20110117171A1 (en) 2009-11-18 2011-05-19 Affinergy, Inc. Implantable bone graft materials
KR101132625B1 (ko) 2010-02-03 2012-04-02 주식회사 바이오랜드 콘택트 렌즈 형태의 양막 드레싱의 제조 방법
US20150010610A1 (en) 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
CA2790436A1 (en) * 2010-02-18 2011-08-25 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
LT2556145T (lt) * 2010-04-07 2016-11-10 Anthrogenesis Corporation Angiogenezė naudojant placentos kamienines ląsteles
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
US20130156863A1 (en) 2010-06-30 2013-06-20 Tissuetech, Inc. Methods of preparing chorion tissue and products derived therefrom
US20120010708A1 (en) 2010-07-08 2012-01-12 AFcell Medical Amnion and chorion replacement cover and uses thereof in surgical repair of muscles
WO2012012410A2 (en) 2010-07-19 2012-01-26 Dr. Reddy's Laboratories Ltd. Kappa opioid receptor agonists
EP2640738A1 (en) 2010-11-15 2013-09-25 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Anti-fungal agents
EP2458043A1 (en) 2010-11-24 2012-05-30 SpinPlant GmbH Product of crosslinked material and method for producing the same
US20120171180A1 (en) 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising amnion derived adherent cells and platelet-rich plasma
US20120189586A1 (en) 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
KR102118457B1 (ko) 2011-02-14 2020-06-03 미메딕스 그룹 인크. 가교제로 변형된 조직 이식편 및 그것의 제조 및 사용 방법
WO2012112410A2 (en) 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
KR20140114277A (ko) 2011-02-14 2014-09-26 미메딕스 그룹 인크. 바르톤 젤리로 이루어진 라미네이트된 조직 이식편 및 그것의 제조 및 사용 방법
EP3311826B1 (en) 2011-02-14 2020-04-29 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
US8967141B2 (en) 2011-09-14 2015-03-03 Brian Anthony Lemper Inhalation systems, breathing apparatuses, and methods
US12290613B2 (en) 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
TW201315479A (zh) 2011-10-12 2013-04-16 Univ Nat Cheng Kung 可促進動脈新生之醫藥組成物、及其製備方法與應用
WO2013082158A1 (en) 2011-12-02 2013-06-06 Mimedx Group Inc. Shredded tissue grafts and methods for making and using the same
US9186382B2 (en) 2011-12-02 2015-11-17 Mimedx Group, Inc. Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same
CA2857636C (en) 2011-12-22 2020-06-23 Mimedx Group Inc. Cross-linked dehydrated placental tissue grafts and methods for making and using the same
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
CA2880157C (en) 2012-08-15 2020-07-21 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US11338063B2 (en) 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US9662355B2 (en) 2013-01-18 2017-05-30 Mimedx Group, Inc. Methods for treating cardiac conditions
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US10335433B2 (en) 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US9446142B2 (en) 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates
WO2015109329A1 (en) * 2014-01-17 2015-07-23 Mimedx Group, Inc. Method for inducing angiogenesis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150010609A1 (en) * 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
WO2013171752A1 (en) * 2012-05-16 2013-11-21 Minovia Therapeutics Ltd. Compositions and methods for inducing angiogenesis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
MIMEDX GROUP: "PURION Processed Dehydrated Human Amnion/Chorion Membrane Allografts INTRODUCTION", PURION PROCESSED DEHYDRATED HUMAN AMNION/CHORION MEMBRANE ALLOGRAFTS, 1 January 2012 (2012-01-01), pages 1 - 12, XP055664054, Retrieved from the Internet <URL:http://www.medserve.ch/Portals/0/Purion%20Process%20Monograph%20July.pdf> [retrieved on 20200131] *
See also references of WO2015109329A1 *
SNYDER ET AL: "Treating Painful Diabetic Peripheral Neuropathy: An Update", AMERICAN FAMILY PHYSICIAN, vol. 94, no. 3, 1 January 2016 (2016-01-01), US, pages 227 - 234, XP055812815, ISSN: 0002-838X *
STEED D L ET AL: "Clinical evaluation of recombinant human platelet - derived growth factor for the treatment of lower extremity diabetic ulcers", JOURNAL OF VASCULAR SURGERY, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 1, 1 January 1995 (1995-01-01), pages 71 - 81, XP005139769, ISSN: 0741-5214, DOI: 10.1016/S0741-5214(95)70245-8 *
THOMAS J KOOB ET AL: "Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing : Biological properties of dehydrated human amnion/chorion grafts", INTERNATIONAL WOUND JOURNAL, vol. 10, no. 5, 1 August 2013 (2013-08-01), UK, pages 493 - 500, XP055566401, ISSN: 1742-4801, DOI: 10.1111/iwj.12140 *
WIEMAN T. J. ET AL: "Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study", DIABETES CARE, vol. 21, no. 5, 1 May 1998 (1998-05-01), US, pages 822 - 827, XP055801904, ISSN: 0149-5992, Retrieved from the Internet <URL:http://dx.doi.org/10.2337/diacare.21.5.822> DOI: 10.2337/diacare.21.5.822 *

Also Published As

Publication number Publication date
AU2015206236B2 (en) 2020-02-20
US20210177910A1 (en) 2021-06-17
AU2015206236A1 (en) 2016-07-21
WO2015109329A1 (en) 2015-07-23
EP3094336A1 (en) 2016-11-23
JP2017507114A (ja) 2017-03-16
JP7464348B2 (ja) 2024-04-09
US10842824B2 (en) 2020-11-24
US10052351B2 (en) 2018-08-21
US20190022146A1 (en) 2019-01-24
US20150216912A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
EP3094336A4 (en) Method for inducing angiogenesis
GB201406151D0 (en) Method
GB201409558D0 (en) Method
GB201406155D0 (en) Method
GB201408119D0 (en) Method
EP3136368A4 (en) External-environment-recognizing apparatus
GB201410262D0 (en) Novel method
EP3113594A4 (en) Parts-placing apparatus
EP3101922A4 (en) Apparatus
EP3214072A4 (en) Method for producing -caprolactam
EP3213813A4 (en) Distillation apparatus
EP3209051A4 (en) Apparatus
EP3196196A4 (en) Method for preparing calcobutrol
GB201403470D0 (en) Method
EP3214062A4 (en) Distillation apparatus
EP3107927A4 (en) Fractionation method
GB201410022D0 (en) Method
EP3213832A4 (en) Spin-molding method
EP3165679A4 (en) Method for slope improvement
EP3242172A4 (en) Method for operating dual controller
EP3136769A4 (en) Apparatus
EP3104642A4 (en) Apparatus
GB201409234D0 (en) Method
GB201409128D0 (en) Method
EP3113531A4 (en) Apparatus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160729

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/073 20100101ALI20170926BHEP

Ipc: A61K 35/50 20150101AFI20170926BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180115

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/50 20150101AFI20180109BHEP

Ipc: C12N 5/073 20100101ALI20180109BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190418

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20210610